• Home
  • About Us
  • Disclaimer
  • Contact
Sunday, February 5, 2023
News Monks
  • .
  • National
    • All
    • Chennai
    • Dehradun
    • Delhi
    • Goa
    • Gujarat
    • Hyderabad
    • Indor
    • Jammu & Kashmir
    • Kolkata
    • Maharashtra
    • Panjab
    • Rajasthan
    • Tamilnadu
    CM interacts with the participating saints of the Gujarat Tirth yatra of Ramakrishna Mission

    CM interacts with the participating saints of the Gujarat Tirth yatra of Ramakrishna Mission

    Chief Minister welcomes the union budget 2023-24: Thanks Prime Minister & congratulates Finance Minister

    Chief Minister welcomes the union budget 2023-24: Thanks Prime Minister & congratulates Finance Minister

    Members of Ahmedabad Chapter who were honored with PRSI national award felicitated at AMA

    Members of Ahmedabad Chapter who were honored with PRSI national award felicitated at AMA

    2nd highest Gross GST collection in January 2023, breaching earlier 2nd highest record in the Month of October 2022

    2nd highest Gross GST collection in January 2023, breaching earlier 2nd highest record in the Month of October 2022

    Kanha Music & Meditation Festival kicks in marking 150th Birth Anniversary Week of Lalaji Maharaj as Sangeet Samragyi Kaushiki Chakraborty renders enchanting music

    Kanha Music & Meditation Festival kicks in marking 150th Birth Anniversary Week of Lalaji Maharaj as Sangeet Samragyi Kaushiki Chakraborty renders enchanting music

    9 out of 10 people in Vadodara have  Vitamin D deficiency: Tata 1mg labs

    9 out of 10 people in Vadodara have Vitamin D deficiency: Tata 1mg labs

    COLORS’ actors send their best wishes on Republic Day!

    COLORS’ actors send their best wishes on Republic Day!

    Governor of Maharashtra releases author Manoj Gursahani’s first book in Mumbai

    Governor of Maharashtra releases author Manoj Gursahani’s first book in Mumbai

    Prime Minister congratulated the citizens on the occasion of Republic Day

    Prime Minister congratulated the citizens on the occasion of Republic Day

    Gujarat CM takes important decision giving rebate on the payment of outstanding municipal taxes

    Gujarat CM takes important decision giving rebate on the payment of outstanding municipal taxes

    Trending Tags

    • Gujarat CM
    • PM Modi
    • Hotel
    • indian team
    • India
    • Indian Army
    • hotstar
    • Gujarati
    • Modi
    • Mrs India
    • corona
    • Covid-19 Coronavirus
    • Gujarat
    • Maharashtra
    • Delhi
    • Rajasthan
    • Jammu & Kashmir
    • Tamilnadu
  • World
  • BusinessIn Trend
    • All
    • Automobile
    • Aviation
    • E Commerce
    • E-Waste
    • Economy
    • Electronics
    • Fashion
    • Finance
    • Food and Beverage
    • Footware
    • Logistics
    • Real Estaete
    • Share Market
    • Solar Energy
    • Telecom
    • Travel
    Chief Minister welcomes the union budget 2023-24: Thanks Prime Minister & congratulates Finance Minister

    Chief Minister welcomes the union budget 2023-24: Thanks Prime Minister & congratulates Finance Minister

    Experience LOVE with Starbucks Valentine’s Specials!

    Experience LOVE with Starbucks Valentine’s Specials!

    Budget Expectations from Marut Drones

    Budget Expectations from Marut Drones

    2nd highest Gross GST collection in January 2023, breaching earlier 2nd highest record in the Month of October 2022

    2nd highest Gross GST collection in January 2023, breaching earlier 2nd highest record in the Month of October 2022

    Kanha Music & Meditation Festival kicks in marking 150th Birth Anniversary Week of Lalaji Maharaj as Sangeet Samragyi Kaushiki Chakraborty renders enchanting music

    Kanha Music & Meditation Festival kicks in marking 150th Birth Anniversary Week of Lalaji Maharaj as Sangeet Samragyi Kaushiki Chakraborty renders enchanting music

    • Automobile
    • Finance
    • Share Market
  • Entertainment
    • Event
    • Movies
    • Television
  • Politics
  • TechHot
    • All
    • Android Os
    • Apple
    • Laptop
    • Mobile
    • SEO / eMarketing
    • Tablet PC
    • Windows
    Budget Expectations from Marut Drones

    Budget Expectations from Marut Drones

    Samsung Launches 2023 Side-by-Side Refrigerator Range  That Will be 100% Made in India, with Features Made for India

    Samsung Launches 2023 Side-by-Side Refrigerator Range That Will be 100% Made in India, with Features Made for India

    The Secretary, MeitY launches Technology for Air Quality Monitoring System (AI-AQMS v1.0)

    The Secretary, MeitY launches Technology for Air Quality Monitoring System (AI-AQMS v1.0)

    Startup India Innovation Week culminates today with felicitation of Winners of National Startup awards 2022

    Startup India Innovation Week culminates today with felicitation of Winners of National Startup awards 2022

    Dholakia Ventures Hosts DV8 Infinite Possibilities-G20 for Start Ups in Surat, Aims to Mobilise Global Capital for Innovation in India

    Dholakia Ventures Hosts DV8 Infinite Possibilities-G20 for Start Ups in Surat, Aims to Mobilise Global Capital for Innovation in India

    • Mobile
    • Laptop
    • SEO / eMarketing
  • More
    • Spiritual
    • Health
    • Sports
      • Cricket
No Result
View All Result
  • .
  • National
    • All
    • Chennai
    • Dehradun
    • Delhi
    • Goa
    • Gujarat
    • Hyderabad
    • Indor
    • Jammu & Kashmir
    • Kolkata
    • Maharashtra
    • Panjab
    • Rajasthan
    • Tamilnadu
    CM interacts with the participating saints of the Gujarat Tirth yatra of Ramakrishna Mission

    CM interacts with the participating saints of the Gujarat Tirth yatra of Ramakrishna Mission

    Chief Minister welcomes the union budget 2023-24: Thanks Prime Minister & congratulates Finance Minister

    Chief Minister welcomes the union budget 2023-24: Thanks Prime Minister & congratulates Finance Minister

    Members of Ahmedabad Chapter who were honored with PRSI national award felicitated at AMA

    Members of Ahmedabad Chapter who were honored with PRSI national award felicitated at AMA

    2nd highest Gross GST collection in January 2023, breaching earlier 2nd highest record in the Month of October 2022

    2nd highest Gross GST collection in January 2023, breaching earlier 2nd highest record in the Month of October 2022

    Kanha Music & Meditation Festival kicks in marking 150th Birth Anniversary Week of Lalaji Maharaj as Sangeet Samragyi Kaushiki Chakraborty renders enchanting music

    Kanha Music & Meditation Festival kicks in marking 150th Birth Anniversary Week of Lalaji Maharaj as Sangeet Samragyi Kaushiki Chakraborty renders enchanting music

    9 out of 10 people in Vadodara have  Vitamin D deficiency: Tata 1mg labs

    9 out of 10 people in Vadodara have Vitamin D deficiency: Tata 1mg labs

    COLORS’ actors send their best wishes on Republic Day!

    COLORS’ actors send their best wishes on Republic Day!

    Governor of Maharashtra releases author Manoj Gursahani’s first book in Mumbai

    Governor of Maharashtra releases author Manoj Gursahani’s first book in Mumbai

    Prime Minister congratulated the citizens on the occasion of Republic Day

    Prime Minister congratulated the citizens on the occasion of Republic Day

    Gujarat CM takes important decision giving rebate on the payment of outstanding municipal taxes

    Gujarat CM takes important decision giving rebate on the payment of outstanding municipal taxes

    Trending Tags

    • Gujarat CM
    • PM Modi
    • Hotel
    • indian team
    • India
    • Indian Army
    • hotstar
    • Gujarati
    • Modi
    • Mrs India
    • corona
    • Covid-19 Coronavirus
    • Gujarat
    • Maharashtra
    • Delhi
    • Rajasthan
    • Jammu & Kashmir
    • Tamilnadu
  • World
  • BusinessIn Trend
    • All
    • Automobile
    • Aviation
    • E Commerce
    • E-Waste
    • Economy
    • Electronics
    • Fashion
    • Finance
    • Food and Beverage
    • Footware
    • Logistics
    • Real Estaete
    • Share Market
    • Solar Energy
    • Telecom
    • Travel
    Chief Minister welcomes the union budget 2023-24: Thanks Prime Minister & congratulates Finance Minister

    Chief Minister welcomes the union budget 2023-24: Thanks Prime Minister & congratulates Finance Minister

    Experience LOVE with Starbucks Valentine’s Specials!

    Experience LOVE with Starbucks Valentine’s Specials!

    Budget Expectations from Marut Drones

    Budget Expectations from Marut Drones

    2nd highest Gross GST collection in January 2023, breaching earlier 2nd highest record in the Month of October 2022

    2nd highest Gross GST collection in January 2023, breaching earlier 2nd highest record in the Month of October 2022

    Kanha Music & Meditation Festival kicks in marking 150th Birth Anniversary Week of Lalaji Maharaj as Sangeet Samragyi Kaushiki Chakraborty renders enchanting music

    Kanha Music & Meditation Festival kicks in marking 150th Birth Anniversary Week of Lalaji Maharaj as Sangeet Samragyi Kaushiki Chakraborty renders enchanting music

    • Automobile
    • Finance
    • Share Market
  • Entertainment
    • Event
    • Movies
    • Television
  • Politics
  • TechHot
    • All
    • Android Os
    • Apple
    • Laptop
    • Mobile
    • SEO / eMarketing
    • Tablet PC
    • Windows
    Budget Expectations from Marut Drones

    Budget Expectations from Marut Drones

    Samsung Launches 2023 Side-by-Side Refrigerator Range  That Will be 100% Made in India, with Features Made for India

    Samsung Launches 2023 Side-by-Side Refrigerator Range That Will be 100% Made in India, with Features Made for India

    The Secretary, MeitY launches Technology for Air Quality Monitoring System (AI-AQMS v1.0)

    The Secretary, MeitY launches Technology for Air Quality Monitoring System (AI-AQMS v1.0)

    Startup India Innovation Week culminates today with felicitation of Winners of National Startup awards 2022

    Startup India Innovation Week culminates today with felicitation of Winners of National Startup awards 2022

    Dholakia Ventures Hosts DV8 Infinite Possibilities-G20 for Start Ups in Surat, Aims to Mobilise Global Capital for Innovation in India

    Dholakia Ventures Hosts DV8 Infinite Possibilities-G20 for Start Ups in Surat, Aims to Mobilise Global Capital for Innovation in India

    • Mobile
    • Laptop
    • SEO / eMarketing
  • More
    • Spiritual
    • Health
    • Sports
      • Cricket
No Result
View All Result
News Monks
No Result
View All Result
ADVERTISEMENT

Recently published data on Favipiravir as treatment for mild to moderate COVID-19 demonstrates significant improvement in time to clinical cure

NewsMonks by NewsMonks
2 years ago
in Health & Fitness
4 min read
0
Uttar Pradesh establishes Integrated COVID Control & Command Centre, and a Unified State COVID Portal
7
SHARES
50
VIEWS
Share on WhatsappShare on FacebookShare on Twitter
ADVERTISEMENT

These findings were observed in a Phase 3 clinical trial conducted by Glenmark Pharmaceuticals and has been published by the globally reputed, peer reviewed International Journal of Infectious Diseases.

The oral antiviral medication Favipiravir, that prevents the replication phase of the virus life-cycle, leads to significant improvement in clinical cure in patients with mild to moderate COVID-19. These findings were observed in a randomized, controlled Phase 3 clinical study conducted by Glenmark Pharmaceuticals, and the results are now published online in The International Journal of Infectious Diseases (IJID). The IJID is a globally reputed, peer-reviewed, pubmed indexed, open access journal published monthly by the International Society for Infectious Diseases, USA. The published findings will also appear in the print edition of the journal in the coming weeks.

Dr Zarir F. Udwadia. MD, FRCP, FCCP, Breach Candy Hospital, Mumbai commented “Every claim for the efficacy of a new drug in COVID-19 must be backed by evidence from a clinical trial. Glenmark has done just that with Favipiravir. Their well-designed trial in 150 patients showed Favipiravir resulted in a significantly improved time to clinical cure and rapid viral clearance. Based on this I would consider the use of this anti-viral drug in symptomatic patients with mild to moderate COVID-19. I eagerly await the results of similar trials presently being conducted in Boston and at Stanford”. 

Mr. Robert Crockart, Chief Commercial Officer Glenmark Pharmaceuticals said, “From the first reported case of COVID-19, our every effort was to bring a viable, safe and effective treatment option to patients in a timely manner. It is encouraging to see our trial results now published in a reputed global medical journal, which we hope will support other countries in their fight against this disease.”

ADVERTISEMENT

“The study, which was undertaken by Glenmark Pharmaceuticals, at a time when the number of cases for infections were dramatically increasing around the globe, demonstrates Glenmark’s commitment to ensuring all patients have access to affordable medication, to make a positive impact on their quality of life,” said Dr. Monika Tandon, Sr. Vice President & Head – Clinical Development, Global Specialty/Branded Portfolio at Glenmark.

The publication on the study titled “Efficacy and Safety of Favipiravir, an Oral RNA-Dependent RNA Polymerase Inhibitor, in Mild-to-Moderate COVID-19:  A Randomized, Comparative, Open-Label, Multicenter, Phase 3 Clinical Trial” was authored by Dr. Zarir .F. Udwadiaand other co-authors .

The link to the article is mentioned below

https://authors.elsevier.com/sd/article/S1201-9712(20)32453-X

The Phase 3 study with antiviral drug Favipiravir, brand name FabiFlu®, was conducted in 150 patients as part of a randomised, open label, multicenter, Phase 3 study. The study aimed to evaluate the efficacy and safety of Favipiravir plus standard supportive care (Favipiravir treatment arm), versus standard supportive care alone (control arm), in mild to moderate patients, randomized within a 48 hour window of testing RT-PCR positive for COVID-19.

Favipiravir was found to provide multiple treatment benefits, demonstrated by faster time to clinical cure, and significantly delayed the need for supportive oxygen therapy. Additionally, patients of confirmed COVID-19 with moderate symptoms were discharged from hospital earlier than those patients that did not receive Favipiravir, with the median time to clinical cure reduced by 2.5 days compared with the control group.

Since it was first pronounced a pandemic by the WHO in March, COVID-19 has continued to impact the lives of millions of people globally. As of date, over 50 mn. cases have been reported, with over 1 mn. deaths attributed to this disease. The virus has reportedly spread to all around the world and territories across the globe. Most disease cases are mild to moderate, with symptoms including fever, cough and breathlessness. In severe cases, COVID-19 can cause pneumonia, severe acute respiratory syndrome, kidney failure and death.

Favipiravir is an antiviral medication that works by inhibiting a viral enzyme called RdRP (RNA dependent RNA polymerase), thereby halting the virus’s replication cycle. This helps control the multiplication of the virus and prevents its spread in the patient. This mechanism of action of Favipiravir is novel compared to most antivirals that primarily prevent entry and exit of the virus from cells. Several published reports are now available of the drug’s effectiveness against COVID-19.

Patients in the Glenmark clinical trial received Favipiravir tablets 3,600 mg (1,800 mg BID) (Day 1) + 1,600 mg (800 mg BID) (Day 2 or later) for up to maximum of 14 days, along with standard supportive care. Randomization was stratified based on disease severity into mild and moderate. Favipiravir was well tolerated with no serious adverse events (SAEs) or deaths in the Favipiravir treated arm. The pre-specified primary endpoint, time from randomisation to cessation of oral shedding of the SARS-CoV-2 virus, demonstrated a 2 day earlier virological cure in the Favipiravir treatment group, though not statistically significant. However, significant improvement in time to clinical cure and other secondary end-points suggest Favipiravir may be beneficial in the treatment of mild-to-moderate COVID-19.  In June 2020, Glenmark received manufacturing and marketing approval from India’s drug regulator for Favipiravir (FabiFlu®), making it the first oral approved medication in India for the treatment of mild to moderate COVID-19. The manufacturing and marketing approval was granted as part of an accelerated approval process, considering the emergency situation of the COVID-19 outbreak in India. The approval’s restricted use entails responsible medication use where every patient must have signed informed consent before treatment initiation.

Tags: covidCovid 19Favipiravir
NewsMonks

NewsMonks

Related Posts

9 out of 10 people in Vadodara have  Vitamin D deficiency: Tata 1mg labs
Economy

9 out of 10 people in Vadodara have Vitamin D deficiency: Tata 1mg labs

January 30, 2023
Reniu clinic Mysore offers Cost effective and Reliable Hair Transplant in Mysore
Business

Reniu clinic Mysore offers Cost effective and Reliable Hair Transplant in Mysore

January 6, 2023
Odisha-based orthopedic surgeon, Dr Sandeep Singh, explains how to distinguish between a ligament tear and a sprain
Health & Fitness

Odisha-based orthopedic surgeon, Dr Sandeep Singh, explains how to distinguish between a ligament tear and a sprain

December 28, 2022

Tags

Acer Agriculture Ahmedabad amazon Automobile Banks bollywood Business Cm gujarat colors Cricket Development Economy education entertainment Environment Fashion festival finance Food and beverage Government gujarat Health Health and Fitness India Insurance International Medical Movies National PayTm Politics samsung SHAMIM MERCHANT shilpa shah SHILPA Shah Director In-charge HKBBA College Social spiritual Sports Technology television Vehicles VR Darshana Ranpura VR Niti Sejpal VR Sunil Gohil
  • Live
  • Upcoming
  • Ended
Pause Play Play Play
SymbolNameLast Price% Change
BrandPAPA - Your Branding Buddy

Ad.

ADVERTISEMENT

NEWS MONKS

News Monks is the News portal who has great reach with the best seo and social media boosting activities. PR agency can contact on newsmonks@gmail.com for more information.

  • About Us
  • Disclaimer
  • Contact

Scan for Mobile

DMCA.com Protection Status

Live Forex Dashboard: 

Forex Rates by TradingView

Hindi News Portal

English, Hindi & Gujarati Poems

Gujarati News Portal

Facebook  | Linkedin  | Instagram

© 2011 – 2021 NewsMonks –  All rights Reserved. Developed & Owned by MediaHives.com

No Result
View All Result
  • .
  • National
    • Gujarat
    • Maharashtra
    • Delhi
    • Rajasthan
    • Jammu & Kashmir
    • Tamilnadu
  • World
  • Business
    • Automobile
    • Finance
    • Share Market
  • Entertainment
    • Event
    • Movies
    • Television
  • Politics
  • Tech
    • Mobile
    • Laptop
    • SEO / eMarketing
  • More
    • Spiritual
    • Health
    • Sports
      • Cricket

© 2021 All Rights Reserved by Media Hives. Designed by eMobitech Solutions.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In